Goldcorp Inc. (NYSE:GG) caters to the Basic Materials space. It has a net profit margin of -56.00% and weekly performance is 12.37%. On the last day of trading company shares ended up at $11.54. Goldcorp Inc. (NYSE:GG) distance from 50-day simple moving average (SMA50) is 0.48%.

Goldcorp Inc. (NYSE:GG) will release 2015 fourth quarter and full-year results after the market close on Thursday, February 25, 2016. The release will also include the Company’s guidance for 2016 and its mineral reserve and mineral resource statement as of December 31, 2015.

NorthStar Realty Finance Corp. (NYSE:NRF) ended the last trading day at $11.69. Company weekly volatility is calculated as 4.73% and price to cash ratio as 5.55. NorthStar Realty Finance Corp. (NYSE:NRF) showed a weekly performance of 1.65%.

NorthStar Realty Finance Corp. (NYSE:NRF) announced that its Board of Directors has declared: (i) a quarterly cash dividend of $0.54688 per share of Series A preferred stock, (ii) a quarterly cash dividend of $0.51563 per share of Series B preferred stock, (iii) a quarterly cash dividend of $0.55469 per share of Series C preferred stock, (iv) a quarterly cash dividend of $0.53125 per share of Series D preferred stock, and (v) a quarterly cash dividend of $0.54688 per share of Series E preferred stock, in each case, payable on February 16, 2016 to shareholders of record on February 8, 2016.

On 01 February, ArcelorMittal SA (ADR) (NYSE:MT) shares fell -2.36% and was closed at $3.73. MT EPS growth in last 5 year was -43.40%. ArcelorMittal SA (ADR) (NYSE:MT) year to date (YTD) performance is -11.61%.

ArcelorMittal SA (ADR) (NYSE:MT) announces that Lou Schorsch, 66, senior executive vice president, member of the Group Management Board and CEO of ArcelorMittal Americas will retire from the company, effective end of February 2016.

Arrowhead Research Corp. (NASDAQ:ARWR) shares fell -0.86% in last trading session and ended the day at $3.45. ARWR has a return on assets of -76.10%. Arrowhead Research Corp. (NASDAQ:ARWR) quarterly performance is -33.53%.

Arrowhead Research Corp. (NASDAQ:ARWR) announced that the European Medicines Agency (EMA) granted Orphan Drug Designation to ARC-AAT for treatment of congenital alpha-1 antitrypsin deficiency. ARC-AAT was also previously granted Orphan Drug Designation by the United States Food and Drug Administration (FDA) in 2015.

Kinder Morgan, Inc. (NYSE:KMI) caters to the Basic Materials space. It has a net profit margin of 2.10% and weekly performance is 8.00%. On the last day of trading company shares ended up at $15.19. Kinder Morgan, Inc. (NYSE:KMI) distance from 50-day simple moving average (SMA50) is -9.71%.

Kinder Morgan, Inc. (NYSE:KMI) closed the previously announced plan to acquire 15 refined products terminals from BP Products North America Inc. in a transaction valued at approximately $350 million. The terminals are key distribution facilities for major refined products consuming markets and have approximately 9.5 million barrels of storage and associated infrastructure in the United States.